Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/j.1752-8062.2010.00212.x http://scihub22266oqcxt.onion/10.1111/j.1752-8062.2010.00212.x C5350695!5350695 !20718816     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20718816 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 269.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 269.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 269.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\20718816 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Clin+Transl+Sci 2010 ; 3 (4 ): 158-69 Nephropedia Template TP {{tp|p=20718816 |t=2010. A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release |pdf=|usr=}}{{20718816 }} gab.com Text A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release JO: Clin Transl Sci http://www.kidney.de/pget.php?&tw=1&pmid=20718816 #FOAvip Treatments for allergic disease block the effects of mediators released from activated mast cells and blood basophils. A panel of fullerene derivatives was synthesized and tested for their ability to preempt the release of allergic mediators in vitro and in vivo. The fullerene C(70)-tetraglycolic acid significantly inhibited degranulation and cytokine production from mast cells and basophils, while C(70)-tetrainositol blocked only cytokine production in mast cells and degranulation and cytokine production in basophils. The early phase of FcepsilonRI inhibition was dependent on the blunted release of intracellular calcium stores, elevations in reactive oxygen species, and several signaling molecules. Gene microarray studies further showed the two fullerene derivatives inhibited late phase responses in very different ways. C(70)-tetraglycolic acid was able to block mast cell-driven anaphylaxis in vivo, while C(70)-tetrainositol did not. No toxicity was observed with either compound. These findings demonstrate the biological effects of fullerenes critically depends on the moieties added to the carbon cage and suggest they act on different FcepsilonRI-specific molecules in mast cells and basophils. These next generation fullerene derivatives represent a new class of compounds that interfere with FcepsilonRI signaling pathways to stabilize mast cells and basophils. Thus, fullerene-based therapies may be a new approach for treating allergic diseases. Twit Text FOAVip A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release ????Clin Transl Sci http://www.kidney.de/pget.php?&tw=1&pmid=20718816 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=20718816 #FOAvip English Wikipedia <ref>{{Cite pmid|20718816 }}</ref> A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release #MMPMID20718816 Norton SK ; Dellinger A ; Zhou Z ; Lenk R ; Macfarland D ; Vonakis B ; Conrad D ; Kepley CL Clin Transl Sci 2010[Aug]; 3 (4 ): 158-69 PMID20718816 show ga Treatments for allergic disease block the effects of mediators released from activated mast cells and blood basophils. A panel of fullerene derivatives was synthesized and tested for their ability to preempt the release of allergic mediators in vitro and in vivo. The fullerene C(70)-tetraglycolic acid significantly inhibited degranulation and cytokine production from mast cells and basophils, while C(70)-tetrainositol blocked only cytokine production in mast cells and degranulation and cytokine production in basophils. The early phase of FcepsilonRI inhibition was dependent on the blunted release of intracellular calcium stores, elevations in reactive oxygen species, and several signaling molecules. Gene microarray studies further showed the two fullerene derivatives inhibited late phase responses in very different ways. C(70)-tetraglycolic acid was able to block mast cell-driven anaphylaxis in vivo, while C(70)-tetrainositol did not. No toxicity was observed with either compound. These findings demonstrate the biological effects of fullerenes critically depends on the moieties added to the carbon cage and suggest they act on different FcepsilonRI-specific molecules in mast cells and basophils. These next generation fullerene derivatives represent a new class of compounds that interfere with FcepsilonRI signaling pathways to stabilize mast cells and basophils. Thus, fullerene-based therapies may be a new approach for treating allergic diseases. |Anaphylaxis/drug therapy/genetics/immunology [MESH] |Animals [MESH] |Basophil Degranulation Test [MESH] |Basophils/*drug effects/immunology [MESH] |Disease Models, Animal [MESH] |Drug Design [MESH] |Female [MESH] |Fullerenes/chemistry/*pharmacology [MESH] |Gene Expression Profiling [MESH] |Humans [MESH] |Hypersensitivity/*drug therapy/genetics/*immunology [MESH] |Immunomodulation/drug effects [MESH] |Intracellular Signaling Peptides and Proteins/immunology/metabolism [MESH] |Mast Cells/*drug effects/immunology [MESH] |Mice [MESH] |Mice, Inbred C57BL [MESH] |Nanomedicine/methods [MESH]A new class of human mast cell and peripheral blood basophil stabilize(epmc).pdf DeepDyve Pubget Overpricing